Prognostication in Advanced Cancer by Combining Actigraphy-Derived Rest-Activity and Sleep Parameters with Routine
Shuchita Dhwiren Patel1, Andrew Davies2, Emma Laing3
1Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XP, UK.
Cancers
|January 21, 2023
Summary
Combining sleep data from actigraphy and diaries with clinical information can predict cancer survival. Machine learning models effectively differentiate between shorter and longer survival times in advanced cancer patients.
Area of Science:
- Oncology
- Palliative Care
- Biomedical Engineering
Background:
- Accurate survival prediction is crucial in oncology and palliative care.
- Existing prognostic models often lack robustness.
- Integrating objective and subjective patient data may improve prognostic accuracy.
Purpose of the Study:
- To assess the feasibility of combining actigraphy, sleep diary, and clinical data for cancer survival prognostication.
- To develop and validate a predictive model for survival in advanced cancer patients.
Main Methods:
- Fifty adult outpatients with advanced cancer and <1 year prognosis were recruited.
- Patients wore a wrist actigraph for 8 days and completed a sleep diary.
- Univariate and regularised multivariate regression (Lasso) were used to identify predictors from 66 variables.
Main Results:
- Forty-nine patients completed the study; 34 died within 1 year.
- A Lasso-derived algorithm successfully differentiated shorter/longer survival (log rank p < 0.0001).
- Predictors of longer survival included sleep efficiency, subjective sleep quality, clinician estimate, global health status, and hemoglobin. Shorter survival was linked to sleep disturbance, neutrophil count, urea, creatinine, and C-reactive protein.
Conclusions:
- Machine learning applied to actigraphy, sleep, and clinical data shows promise for developing novel prognostic tools in oncology.
- Objective sleep and activity data, alongside subjective reports and clinical markers, can contribute to more accurate survival predictions.
- This integrated approach may enhance personalized palliative care and treatment planning for advanced cancer patients.


